Can AI help doctors detect vision loss years before permanent damage occurs? 👁️🤖
The future of business, AI, and innovation isn't built without friction. On the Zero Friction Podcast, brought to you by RevRx AI, we explore the groundbreaking ideas, technologies, and visionary leaders shaping what comes next.
In this exclusive episode, our host Terry sits down with Kasia Hein-Peters, MD, CEO of Evoq Technologies, to discuss how AI-powered diagnostics and functional vision testing could transform the future of eye care. From her journey as a psychiatrist in post-communist Poland to helping launch Prozac across Central and Eastern Europe, Kasia shares how decades of leadership in pharmaceuticals and MedTech have led her to tackle one of ophthalmology's biggest challenges: detecting retinal disease before irreversible vision loss occurs.
Discover how Evoq's innovative Twilight Dark Adaptometer measures retinal function years before structural damage becomes visible, enabling physicians to intervene earlier, improve patient outcomes, and preserve independence for millions at risk of vision loss. Kasia also shares her commercialization strategy, fundraising journey, and how AI is reshaping medical education, physician engagement, and the future of healthcare innovation.
If you're a MedTech entrepreneur, healthcare executive, ophthalmologist, investor, or AI enthusiast, this episode offers valuable insights into the future of diagnostics, preventative medicine, and healthcare commercialization.
🔗 Important Links & Resources
🌐 Evoq Technologies Website: https://goevoq.com/
💼 Connect with Kasia Hein-Peters on LinkedIn: / kasiaheinpeters
🤖 Learn more about RevRx AI: https://revrxai.com/
#ZeroFrictionPodcast #RevRxAI #KasiaHeinPeters #EvoqTechnologies